{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:02:26Z","timestamp":1770872546816,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12010-025-05476-x","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T07:09:33Z","timestamp":1762585773000},"page":"344-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interplay of Molecular Subtypes Associated with Butyrate Metabolism Elucidates Clinical Characteristics and Tumor Microenvironment in Prostate Cancer"],"prefix":"10.1007","volume":"198","author":[{"given":"Gang","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"3","key":"5476_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H. Y. A., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin, 74(3), 229\u2013263.","journal-title":"CA-Cancer J Clin"},{"issue":"6","key":"5476_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","volume":"209","author":"W Lowrance","year":"2023","unstructured":"Lowrance, W., Dreicer, R., Jarrard, D. F., et al. (2023). Updates to advanced prostate cancer: AUA\/SUO guideline (2023). Journal of Urology, 209(6), 1082\u20131090.","journal-title":"Journal of Urology"},{"key":"5476_CR3","doi-asserted-by":"crossref","unstructured":"Liu, J. Z., Dong, L., Zhu, Y. J. (2022). Prostate cancer treatment-China? perspective. Cancer Letters, 550","DOI":"10.1016\/j.canlet.2022.215927"},{"issue":"8889","key":"5476_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0140-6736(94)90837-0","volume":"343","author":"MC Bishop","year":"1994","unstructured":"Bishop, M. C. (1994). Treatment of advanced prostate cancer. Lancet (London England), 343(8889), 110\u2013111.","journal-title":"Lancet (London England)"},{"issue":"2","key":"5476_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner, M. C., Zwart, W., Roudier, M. P., et al. (2021). Genomic and phenotypic heterogeneity in prostate cancer. Nature Reviews. Urology, 18(2), 79\u201392.","journal-title":"Nature Reviews. Urology"},{"key":"5476_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pharmthera.2021.107932","volume":"228","author":"M Adamaki","year":"2021","unstructured":"Adamaki, M., & Zoumpourlis, V. (2021). Prostate cancer biomarkers: From diagnosis to prognosis and precision-guided therapeutics. Pharmacology & Therapeutics, 228, 24.","journal-title":"Pharmacology & Therapeutics"},{"issue":"18","key":"5476_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/advs.202305724","volume":"11","author":"XJ Bian","year":"2024","unstructured":"Bian, X. J., Wang, W. F., Abudurexiti, M., et al. (2024). Integration analysis of Single-Cell Multi-Omics reveals prostate cancer heterogeneity. Adv Sci, 11(18), 21.","journal-title":"Adv Sci"},{"issue":"24","key":"5476_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI168670","volume":"133","author":"N Jing","year":"2023","unstructured":"Jing, N., Zhang, K., Chen, X. Y., et al. (2023). ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. J Clin Invest, 133(24), 19.","journal-title":"J Clin Invest"},{"key":"5476_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fimmu.2021.612826","volume":"12","author":"M Hanus","year":"2021","unstructured":"Hanus, M., Parada-Venegas, D., Landskron, G., et al. (2021). Immune System, Microbiota, and microbial metabolites: The unresolved triad in colorectal cancer microenvironment. Frontiers in Immunology, 12, 16.","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"5476_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","volume":"13","author":"DR Donohoe","year":"2011","unstructured":"Donohoe, D. R., Garge, N., Zhang, X. X., et al. (2011). The Microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab, 13(5), 517\u2013526.","journal-title":"Cell Metab"},{"issue":"1","key":"5476_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh, N., Gurav, A., Sivaprakasam, S., et al. (2014). Activation of Gpr109a, receptor for niacin and the commensal metabolite Butyrate, suppresses colonic inflammation and carcinogenesis. Immunity, 40(1), 128\u2013139.","journal-title":"Immunity"},{"issue":"7480","key":"5476_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N., Campbell, C., Fan, X. Y., et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504(7480), 451\u2013.","journal-title":"Nature"},{"key":"5476_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-4598-10-70","volume":"10","author":"M Isra\u00ebl","year":"2011","unstructured":"Isra\u00ebl, M., & Schwartz, L. (2011). The metabolic advantage of tumor cells. Molecular Cancer, 10, 12.","journal-title":"Molecular Cancer"},{"issue":"7","key":"5476_CR14","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/ptr.7785","volume":"37","author":"LP Wang","year":"2023","unstructured":"Wang, L. P., Han, H. T., Feng, Y., et al. (2023). Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS\/AMPK\/mTOR pathway. Phytotherapy Research: Ptr, 37(7), 2902\u20132914.","journal-title":"Phytotherapy Research: Ptr"},{"issue":"11","key":"5476_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garz\u00f3n","year":"2017","unstructured":"Murillo-Garz\u00f3n, V., & Kypta, R. (2017). WNT signalling in prostate cancer. Nature Reviews. Urology, 14(11), 683\u2013696.","journal-title":"Nature Reviews. Urology"},{"issue":"1","key":"5476_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12967-022-03656-5","volume":"20","author":"R Zhang","year":"2022","unstructured":"Zhang, R., & Liu, F. (2022). Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. J Transl Med, 20(1), 18.","journal-title":"J Transl Med"},{"key":"5476_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2023.1148898","volume":"14","author":"YF Feng","year":"2023","unstructured":"Feng, Y. F., Deng, Y. L., Tang, Z. F., et al. (2023). Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer. Frontiers in Endocrinology, 14, 12.","journal-title":"Frontiers in Endocrinology"},{"key":"5476_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.intimp.2024.112599","volume":"138","author":"B Guan","year":"2024","unstructured":"Guan, B., Huang, C., Meng, L. B., et al. (2024). Dissecting prostate cancer: Single-Cell insight into macrophage Diversity, molecular Prognosticators, and the role of Peptidylprolyl isomerase F. International Immunopharmacology, 138, 9.","journal-title":"International Immunopharmacology"},{"key":"5476_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fimmu.2022.997765","volume":"13","author":"YG Lv","year":"2022","unstructured":"Lv, Y. G., Wu, L. Y., Jian, H., et al. (2022). Identification and characterization of aging\/senescence-induced genes in osteosarcoma and predicting clinical prognosis. Frontiers in Immunology, 13, 17.","journal-title":"Frontiers in Immunology"},{"key":"5476_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fimmu.2023.1145552","volume":"14","author":"HX Cui","year":"2023","unstructured":"Cui, H. X., Ren, X. T., Dai, L. Y., et al. (2023). Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer. Frontiers in Immunology, 14, 17.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"5476_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12877-023-04426-8","volume":"23","author":"H Lyu","year":"2023","unstructured":"Lyu, H., & Jiang, W. H. (2023). Development and internal and external validation of a nomogram model for frailty risk among hospitalised older people using comprehensive geriatric assessment data. Bmc Geriatrics, 23(1), 11.","journal-title":"Bmc Geriatrics"},{"issue":"2","key":"5476_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.currproblcancer.2020.100660","volume":"45","author":"HY Zhou","year":"2021","unstructured":"Zhou, H. Y., Chen, L. H., Lei, Y. J., et al. (2021). Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer. Current Problems in Cancer, 45(2), 15.","journal-title":"Current Problems in Cancer"},{"issue":"1","key":"5476_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12967-021-03224-3","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan, C., Niu, Y. D., Li, F., et al. (2022). System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. J Transl Med, 20(1), 19.","journal-title":"J Transl Med"},{"key":"5476_CR24","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","volume":"23","author":"HW Liu","year":"2024","unstructured":"Liu, H. W., Zhang, W., Zhang, Y. H., et al. (2024). Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comp Struct Biotechnol J, 23, 2798\u20132810.","journal-title":"Comp Struct Biotechnol J"},{"issue":"1","key":"5476_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12885-024-13409-w","volume":"25","author":"YC Luan","year":"2025","unstructured":"Luan, Y. C., Liang, C., Han, Q. S., et al. (2025). The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment. Bmc Cancer, 25(1), 18.","journal-title":"Bmc Cancer"},{"issue":"7","key":"5476_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nmeth.1607","volume":"8","author":"K Colwill","year":"2011","unstructured":"Colwill, K., Gr\u00e4slund, S., & Binder Working, R. P. (2011). A roadmap to generate renewable protein binders to the human proteome. Nature Methods, 8(7), 551\u2013U52.","journal-title":"Nature Methods"},{"issue":"3","key":"5476_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms24031980","volume":"24","author":"EA Sidorova","year":"2023","unstructured":"Sidorova, E. A., Zhernov, Y. V., Antsupova, M. A., et al. (2023). The role of different types of MicroRNA in the pathogenesis of breast and prostate cancer. International Journal of Molecular Sciences, 24(3), 17.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"5476_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jgm.3016","volume":"20","author":"OE Bryzgunova","year":"2018","unstructured":"Bryzgunova, O. E., Konoshenko, M. Y., & Laktionov, P. P. (2018). MicroRNA-guided gene expression in prostate cancer: Literature and database overview. The Journal of Gene Medicine, 20(5), 19.","journal-title":"The Journal of Gene Medicine"},{"key":"5476_CR29","doi-asserted-by":"crossref","unstructured":"Cochran, B. H., Zullo, J., Verma, I. M., et al. (1984). Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor. Science (New York, NY), 226(4678): 1080\u20132","DOI":"10.1126\/science.6093261"},{"issue":"7","key":"5476_CR30","first-page":"12","volume":"39","author":"L Anuj, Arivazhagan","year":"2019","unstructured":"Anuj, Arivazhagan, L., Venkatraman, G., et al. (2019). Increased expression of MicroRNA 551a by c-Fos reduces focal adhesion kinase levels and blocks tumorigenesis. Molecular and Cellular Biology, 39(7), 12.","journal-title":"Molecular and Cellular Biology"},{"key":"5476_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.biopha.2018.08.157","volume":"107","author":"JB Zhou","year":"2018","unstructured":"Zhou, J. B., Wang, M. C., & Deng, D. F. (2018). c-Fos\/microRNA-18a feedback loop modulates the tumor growth via HMBOX1 in human gliomas. Biomedicine & Pharmacotherapy, 107, 1705\u20131711.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"D1","key":"5476_CR32","doi-asserted-by":"publisher","first-page":"D253","DOI":"10.1093\/nar\/gky1023","volume":"47","author":"Z Tong","year":"2019","unstructured":"Tong, Z., Cui, Q. H., Wang, J., et al. (2019). TransmiR v2.0: An updated transcription factor-microRNA regulation database. Nucleic Acids Research, 47(D1), D253\u2013D8.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"5476_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41598-023-50735-8","volume":"14","author":"LH Yang","year":"2024","unstructured":"Yang, L. H., Ruan, Y., Chen, B., et al. (2024). Circ_0001671 regulates prostate cancer progression through miR-27b-3p\/BLM axis. Scientific Reports, 14(1), 11.","journal-title":"Scientific Reports"},{"issue":"1","key":"5476_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41467-024-45475-w","volume":"15","author":"NM Fonseca","year":"2024","unstructured":"Fonseca, N. M., Maurice-Dror, C., Herberts, C., et al. (2024). Prediction of plasma ctdna fraction and prognostic implications of liquid biopsy in advanced prostate cancer. Nature Communications, 15(1), 16.","journal-title":"Nature Communications"},{"key":"5476_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcancer.2021.08.004","volume":"86","author":"V Vlaeminck-Guillem","year":"2022","unstructured":"Vlaeminck-Guillem, V. (2022). Exosomes and prostate cancer management. Semin Cancer Biol, 86, 101\u2013111.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5476_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41467-023-35880-y","volume":"14","author":"T Tsujino","year":"2023","unstructured":"Tsujino, T., Takai, T., Hinohara, K., et al. (2023). CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications, 14(1), 19.","journal-title":"Nature Communications"},{"key":"5476_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ebiom.2024.105168","volume":"105","author":"TA Desai","year":"2024","unstructured":"Desai, T. A., Hedman, A. K., Dimitriou, M., et al. (2024). Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian randomisation and tumour Spatial transcriptomics. EBioMedicine, 105, 16.","journal-title":"EBioMedicine"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05476-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T04:04:09Z","timestamp":1770869049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5476"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05476-x","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"19 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research was approved by the local ethics committee based on the Declaration of Helsinki. Written consent was obtained from each patient before surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"No conflict of interest was declared by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}